A Comparative Study of KSO-0400 in BPH Patients With LUTS

NCT01222650 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Prostatic Hyperplasia (BPH)

Interventions

DRUG: KSO-0400
DRUG: KSO-0400
DRUG: Silodosin
DRUG: Placebo

Sponsor

Kissei Pharmaceutical Co., Ltd.